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Research
Correspondence Chocolate Consumption and Risk of Stroke in WomenTo the Editor: Ample evidence indicates that chocolate may have
beneficial effects on the cardiovascular system. Chocolate con-
sumption has been shown to reduce systolic and diastolic blood
pressure in short-term randomized feeding trials (1), and has been
demonstrated to improve endothelial and platelet function and to
ameliorate insulin resistance (2). Moreover, flavonoids in chocolate
possess strong antioxidant activity and can suppress oxidation of
low-density lipoprotein cholesterol (3).
We examined the association between chocolate consumption
and risk of stroke in the population-based Swedish Mammography
Cohort. In the autumn of 1997, 39,227 women completed a
questionnaire that included approximately 350 items concerning
diet and other lifestyle factors (4). We excluded women with a
missing national identification number, those with implausible
values for total energy intake, and those with a history of cancer,
stroke, coronary heart disease, or diabetes mellitus before baseline.
That left 33,372 women, age 49 to 83 years, for analysis. The study
was approved by the Ethical Review Board at the Karolinska
Institutet (Stockholm, Sweden). Chocolate consumption was as-
sessed using a self-administered food-frequency questionnaire.
Women were asked to indicate how often on average they had
consumed chocolate and 95 other foods during the previous year.
There were 8 pre-defined consumption categories ranging from
never to 3 times a day. In the 1990s, approximately 90% of
chocolate consumption in Sweden was milk chocolate, containing
approximately 30% cocoa solids (5). The food-frequency question-
naire has been validated, and the Spearman correlation coefficient
between chocolate intake estimated from the questionnaire and the
intake estimated from 28 days of weighted diet records (4 1-week
records completed approximately 3 months apart) was 0.4
(A. Wolk, unpublished data, 1992).
Incident cases of first stroke that occurred between January 1,
1998 (information on exact date of returning of the questionnaire
was not available), and December 31, 2008, were ascertained by
linkage with the Swedish Hospital Discharge Registry. The stroke
events were classified as cerebral infarction (International Classi-
fication of Diseases-10th revision [ICD-10] code I63), intracere-
bral hemorrhage (I61), subarachnoid hemorrhage (I60), and un-
specified stroke (I64). Information on dates of death was obtained
from the Swedish Cause of Death Registry. The Swedish Hospital
Discharge Registry provided information on diagnoses of atrial
fibrillation (ICD-10 code I48). Cox proportional hazards models
with age as the time scale was used to estimate relative risk (RR)
and 95% confidence interval (CI) of stroke by exact quartiles of
chocolate consumption based on the distribution in the cohort.
Entry time was defined as a subject’s age in months at start of
follow-up, and exit time was defined as a subject’s age in months
at stroke diagnosis, death, or end of follow-up. The analyses were
performed using SAS version 9.2 (SAS Institute Inc., Cary, North
Carolina). All p values were 2-sided.
During a mean follow-up of 10.4 years, we ascertained 1,549
events of stroke, including 1,200 cerebral infarctions, 224 hemor-rhagic strokes, and 125 unspecified strokes. Chocolate consump-
tion was inversely associated with risk of total stroke, cerebral
infarction, and hemorrhagic stroke (Table 1). The multivariable
RRs for a 50 g/week increase of chocolate consumption were 0.86
(95% CI: 0.77 to 0.96) for total stroke, 0.88 (95% CI: 0.77 to 0.99)
for cerebral infarction, and 0.73 (95% CI: 0.54 to 0.99) for
hemorrhagic stroke. The difference in risk estimates for cerebral
infarction and hemorrhagic stroke was not significant (p  0.28).
The association for total stroke persisted after excluding the first
year of follow-up (50 g/week increase in intake RR: 0.86; 95% CI:
0.76 to 0.96). In stratified analysis by hypertension, the multivari-
able RRs of total stroke for 50 g per week increment of chocolate
consumption were 0.89 (95% CI: 0.73 to 1.09) for women with a
history of hypertension and 0.85 (95% CI: 0.74 to 0.97) for women
without hypertension.
Our findings are broadly consistent with those from previous
smaller studies, which observed either a statistically significant (136
stroke cases) (6) or a nonsignificant (111 or 469 stroke cases) (5,7)
inverse association between chocolate consumption and total stroke.
In the present study, only women in the highest quartile of chocolate
consumption (median 66.5 g/week) had a significantly reduced risk of
stroke, suggesting that higher intakes are necessary for a potential
protective effect. The reason for the stronger association observed for
hemorrhagic stroke than for cerebral infarction is unclear.
Strengths of this study include its prospective and population-
based design, the nearly complete follow-up of participants through
linkage with population-based Swedish registers, and the large num-
ber of stroke cases. A limitation is that chocolate consumption was
self-reported, which will inevitably lead to some measurement error.
Because of the prospective design, any misclassification of chocolate
consumption is most likely to be nondifferential, leading to an
attenuation of the true association between chocolate consumption
and stroke. Although we adjusted for major risk factors for stroke, we
cannot exclude the possibility that our results may have been affected
by residual or unmeasured confounding. However, the similar results
in the age-adjusted and multivariable models argue against the
possibility of strong residual confounding.
In summary, results from this cohort of women suggest that a high
chocolate consumption is associated with a lower risk of stroke.
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What’s in the Name?
I have read with interest the report by Noseworthy et al. (1) on the
prevalence and heritability of the early repolarization pattern
(ERP) in the general population. The ERP has for a long time
been considered a benign electrocardiographic finding, but recent
studies have challenged this view by reporting a significant asso-
ciation with ventricular tachyarrhythmias and sudden cardiac death
(2–5). Thus, knowledge of its prevalence and determinants in the
general population is relevant for putting ERP in the right clinical
perspective. There are 2 major points in Noseworthy et al.’s study,
however, that, in my opinion, deserve comment.
The ERP in this study was defined as “J-point elevation of0.1definition similar to that applied in recent studies (2–5). However,
how the J point was identified on the electrocardiogram was not
specified in any of these studies. I think this issue is relevant,
because identification of the J wave cannot be taken for granted. A
careful reading of previous studies, indeed, leaves doubts regarding
how the J point was located, in particular in the presence of
prominent notched or slurred J waves (2–5), and inevitably, a
similar concern holds true for the present study (1). Moreover, the
definition of the ERP given in this and in recent studies does not
fit with what clinical cardiologists usually diagnose as the ERP in
their routine clinical practice. In the classic definition of the ERP,
the presence of typical up-sloping ST-segment elevation is specif-
ically required (6,7), but this is not taken into any account in the
definition adopted in this and in previous studies (1–5).
A second questionable point of the study by Noseworthy et al.typesh Cod Stro
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